AI assistant
CELLULAR GOODS PLC Director's Dealing 2022
5058_dirs_2022-03-08_148647d9-dc26-4982-a3e0-6468991f113a.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0287E
Cellular Goods PLC
08 March 2022
08 March 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Share purchase by CEO
Cellular Goods (LSE: CBX), a UK-based wellness company that provides premium consumer products formulated with lab-made cannabinoids, announces that on 03, 04 and 07 March 2022, Anna Chokina, Chief Executive Officer of the Company, purchased in aggregate 226,000 ordinary shares in the capital of the Company ("Ordinary Shares") at an average price per share of 3.46 pence.
The transactions are Mrs. Chokina's first open market purchases since her appointment on 06 December 2021. The details of the transaction are disclosed below.
The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Anna Chokina
2.
Reason for the Notification
a)
Position/status
PDMR
b)
Initial notification / Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cellular Goods PLC
b)
LEI
213800IXPX4Z2MKX2U28
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares
Identification Code
GB00BK964W87
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.8 pence per Ordinary Share | 75,000 Ordinary Shares |
d)
Aggregated information:
· Aggregated volume
· Price
75,000 Ordinary Shares
3.8 pence per Ordinary Share
e)
Date of the transaction
03 March 2022
f)
Place of the Transaction
London Stock Exchange
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Anna Chokina
2.
Reason for the Notification
a)
Position/status
PDMR
b)
Initial notification / Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cellular Goods PLC
b)
LEI
213800IXPX4Z2MKX2U28
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares
Identification Code
GB00BK964W87
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.3 pence per Ordinary Share | 150,000 Ordinary Shares |
d)
Aggregated information:
· Aggregated volume
· Price
150,000 Ordinary Shares
3.3 pence per Ordinary Share
e)
Date of the transaction
04 March 2022
f)
Place of the Transaction
London Stock Exchange
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Anna Chokina
2.
Reason for the Notification
a)
Position/status
PDMR
b)
Initial notification / Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cellular Goods PLC
b)
LEI
213800IXPX4Z2MKX2U28
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares
Identification Code
GB00BK964W87
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 2.6 pence per Ordinary Share | 1,000 Ordinary Shares |
d)
Aggregated information:
· Aggregated volume
· Price
1,000 Ordinary Shares
2.6 pence per Ordinary Share
e)
Date of the transaction
07 March 2022
f)
Place of the Transaction
London Stock Exchange
For further information please contact:
| Cellular Goods | |
| Anna Chokina Chief Executive Neil Thapar Investor Relations |
via Tancredi +44 207 887 7633 +44 787 645 5323 |
| Tennyson Securities | |
| Corporate Broker Peter Krens |
+44 207 186 9030 |
| Novum Securities | |
| Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
| Tancredi Intelligent Communication | |
| Media Relations Helen Humphrey Gabriela Amaya Garcia Edward Daly Charlie Hobbs [email protected] |
+44 744 922 6720 +44 791 503 5294 +44 786 143 0057 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular's premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAFDPEEFAEFA